These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36563769)

  • 1. Research advances on targeted-Treg therapies on immune-mediated kidney diseases.
    Li Y; Liu H; Yan H; Xiong J
    Autoimmun Rev; 2023 Feb; 22(2):103257. PubMed ID: 36563769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.
    Kant S; Kronbichler A; Sharma P; Geetha D
    Am J Kidney Dis; 2022 Apr; 79(4):582-600. PubMed ID: 34508831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China.
    Chen L; Luodelete M; Dong C; Li B; Zhang W; Nie P; Liu J; Chen X; Luo P
    Ren Fail; 2019 Nov; 41(1):473-480. PubMed ID: 31198075
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis and treatment of glomerulonephritis-an update.
    Couser WG
    J Bras Nefrol; 2016 Mar; 38(1):107-22. PubMed ID: 27049372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the Genetic Code of Autoimmune Kidney Diseases.
    Huang SU; Kulatunge O; O'Sullivan KM
    Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
    Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
    Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of complement in glomerulonephritis-are novel therapies ready for prime time?
    Cheung CK; Dormer JP; Barratt J
    Nephrol Dial Transplant; 2023 Jul; 38(8):1789-1797. PubMed ID: 36307926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II Type 1 Receptor Antibodies Are Higher in Lupus Nephritis and Vasculitis than Other Glomerulonephritis Patients.
    Szymczak M; Heidecke H; Żabińska M; Rukasz D; Wiśnicki K; Tukiendorf A; Krajewska M; Banasik M
    Arch Immunol Ther Exp (Warsz); 2022 Sep; 70(1):23. PubMed ID: 36152104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-glomerular basement membrane vasculitis.
    Ponticelli C; Calatroni M; Moroni G
    Autoimmun Rev; 2023 Jan; 22(1):103212. PubMed ID: 36252931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CKD therapy to improve outcomes of immune-mediated glomerular diseases.
    Anders HJ; Fernandez-Juarez GM; Vaglio A; Romagnani P; Floege J
    Nephrol Dial Transplant; 2023 Nov; 38(Supplement_2):ii50-ii57. PubMed ID: 37218706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerulonephritis Histopathological Pattern Change.
    AlYousef A; AlSahow A; AlHelal B; Alqallaf A; Abdallah E; Abdellatif M; Nawar H; Elmahalawy R
    BMC Nephrol; 2020 May; 21(1):186. PubMed ID: 32423387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix metalloproteinases 2 and 1 in the glomeruli of human glomerular diseases: the results of studies using immunofluorescence, in situ hybridization, and immunoelectron microscopy.
    Sekiuchi M; Kudo A; Nakabayashi K; Kanai-Azuma M; Akimoto Y; Kawakami H; Yamada A
    Clin Exp Nephrol; 2012 Dec; 16(6):863-74. PubMed ID: 22614167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid factors and glomerulonephritis.
    Miyazaki M; Endoh M; Suga T; Yano N; Kuramoto T; Matsumoto Y; Eguchi K; Yagame M; Miura M; Nomoto Y
    Clin Exp Immunol; 1990 Aug; 81(2):250-5. PubMed ID: 2201469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary and secondary glomerular diseases].
    Birck R; Banas B; Benck U
    Dtsch Med Wochenschr; 2016 Aug; 141(16):1158-60. PubMed ID: 27509344
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
    Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
    Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
    J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells in immune-mediated renal disease.
    Ghali JR; Wang YM; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2016 Feb; 21(2):86-96. PubMed ID: 26206106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
    Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
    Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxiredoxins as Markers of Oxidative Stress in IgA Nephropathy, Membranous Nephropathy and Lupus Nephritis.
    Krata N; Foroncewicz B; Zagożdżon R; Moszczuk B; Zielenkiewicz M; Pączek L; Mucha K
    Arch Immunol Ther Exp (Warsz); 2021 Dec; 70(1):3. PubMed ID: 34914001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.